Thank you for the question.
In those 14 countries we've had two cohorts that were part of our commercialization efforts. One was in the Netherlands at Utrecht University and the other was in Australia through the University of Melbourne. Those cohorts have happened just in the last year.
Adaptations will be needed. We're working with the investigators at those universities to modify them. The course that was offered at Utrecht University was translated into Dutch. There will be tweaks. Overall, the fundamental principles still apply. In fact, those fundamental principles can apply to other conditions, not just neurodevelopmental. It's the model that's being followed.